Vital capacity as a predictor of incident type 2 diabetes: The Atherosclerosis Risk in Communities Study

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1472-1479

  Yeh, Hsin Chieh ^a   Punjabi, Naresh M ^a,b   Wang, Nae Yuh ^b   Pankow, James S ^c   Duncan, Bruce B ^d   Brancati, Frederick L ^a,b,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREDICTION; PROSPECTIVE STUDY; RACE; RISK FACTOR; SMOKING; SPIROMETRY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAL CAPACITY;

ARTERIOSCLEROSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EDUCATIONAL STATUS; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; SMOKING; VITAL CAPACITY;

EID: 19944401569     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1472     Document Type: Article

References (46)

1. Hjalmarsen A, Aasebo U, Birkeland K, Sager G, Jorde R: Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab 22:37-42, 1996
2. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F: The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504: 241-249, 1997
3. Lazarus R, Sparrow D, Weiss ST: Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 12:641-645, 1998
4. Engstrom G, Janzon L: Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 19:167-170, 2002
5. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L: Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 253:574-581, 2003
6. Braun B, Rock PB, Zamudio S, Wolfel GE, Mazzeo RS, Muza SR, Fulco CS, Moore LG, Butterfield GE: Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91:623-631, 2001
7. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649-1652, 1999
8. Semenza GL: Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1:159-162, 2000
9. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019-1022, 1991
10. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO: Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 303:671-675, 1991
11. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, Jensen G, Schnohr P: Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Rrespir J 2:14-19, 1989
12. Barrett-Connor E, Frette C: NIDDM, impaired glucose tolerance, and pulmonary function in older adults: the Rancho Bernardo Study. Diabetes Care 19:1441-1444, 1996
13. Davis TME, Knuiman M, Kendall P, Vu H, Davis WA: Reduced pulmonary function and its association in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 50:153-159, 2000
14. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ: Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 167:911-916, 2003
15. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129: 687-702, 1989
16. Ferris BG Jr, Speizer FE, Bishop Y, Prang G, Weener J: Spirometry for an epidemiologic study: Deriving optimum summary statistics for each subject. Bull Europ Physiopath Resp 14:146-166, 1978
17. Gardner RM, et al.: ATS statement: Snow-bird workshop on standarization of spirometry. Am Rev Respir Dis 119:831-838, 1979
18. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259, 2000
19. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G, the Atherosclerosis Risk in Communities Study: Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 52:1799-1805, 2003
20. Crapo RO, Morris AH, Gardner RM: Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123: 659-664, 1981
21. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens CH, Speizer FE: Physical activity and incidence of non-insulin dependent diabetes mellitus in women. Lancet 338:774-778, 1991
22. Shaten BJ, Smith GD, Kuller LH, and Neaton JD: Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care 16:1331-1339, 1993
23. Eriksson KF, Lindgarde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39:573-579,
24. Kannel WB, Hubert H, Lew EA: Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 105:311-315, 1983
25. Ford ES, Mannino DM: Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27:2966-2970, 2004
26. Cheng N, Cai W, Jiang M, Wu S: Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 41:852-856, 1997
27. Raff H, Bruder ED, Jankowski BM: The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 11:37-39, 1999
28. Pollard AJ, Barry PW, Mason NP, Collier DJ, Pollard RC, Pollard PF, Martin I, Fraser RS, Miller MR, Milledge JS: Hypoxia, hypocapnia and spirometry at altitude. Clin Sci (Lond) 92:593-598, 1997
29. Halliwill JR, Minson CT: Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans. J Appl Physiol 93:857-864, 2002
30. Smith ML, Muenter NK: Effects of hypoxia on sympathetic neural control in humans. Respir Physiol 121:163-171, 2000
31. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D: A prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study, 1987-1998. Circulation 107:2190-2195, 2003
32. Santos JL, Perez-Bravo F, Carrasco E, Calvillan M, Albala C: Low prevalence of type 2 diabetes despite a high average body mass index in the Aymara natives from Chile. Nutrition 17:305-309, 2001
33. de Glisezinski I, Crampes F, Harant I, Havlik P, Gardette B, Jammes Y, Souberbielle JC, Richalet JP, Riviere D: Decrease of subcutaneous adipose tissue lipolysis after exposure to hypoxia during a simulated ascent of Mt Everest. Pflugers Arch 439:134-140, 1999
34. Lee WC, Chen JJ, Hunt DD, Hou CW, Lai YC, Lin FC, Chen CY, Lin CH, Liao YH, Kuo CH: Effects of hiking at altitude on body composition and insulin sensitivity in recovering drug addicts. Prev Med 39: 681-688, 2004
35. Sauerwein HP, Schols AM: Glucose metabolism in chronic lung disease. Clin Nutr 21:367-371, 2002
36. Krampl E, Kametas NA, Nowotny P, Roden M, Nicolaides KH: Glucose metabolism in pregnancy at high altitude. Diabetes Care 24:817-822, 2001
37. Cook JT, Levy JC, Page RC, Shaw JA, Hattersley AT, Turner RC: Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 306: 302-306, 1993
38. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C: Thinness at birth and insulin resistance in adult life. Diabetologia 37: 150-154, 1994
39. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D: The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 133: 176-182, 2000
40. Gunnell D, Whitley E, Upton MN, McConnachie A, Davey Smith G, Watt GC: Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health 57:141-146, 2003
41. Asao K, Kao WHL, Baptiste-Roberts K, Bandeen-Roche K, Erlinger T, Brancati L: Upper leg length and glucose tolerance in U.S. adults: NHANES III (Abstract). Circulation 107:E7005, 2003
42. Wannamethee SG, Shaper AG, Perry IJ, the British Regional Heart Study: Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 24:1590-1595, 2001
43. Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med 109:538-542, 2000
44. Zalokar JB, Richard JL, Claude JR: Leukocyte count, smoking, and myocardial infarction. N Engl J Med 304:465-468, 1981
45. Lazarus R, Sparrow D, Weiss ST: Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism 46: 1266-1269, 1997
46. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001